Utah Medical Products, Inc. (UTMD)
Oxford Ledge is still expanding full research coverage of UTMD. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Utah Medical Products manufactures safety-focused medical devices for critical care sold domestically and internationally through direct channels and distributors.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2026-05-12
- 8-K Shareholder vote results 2026-05-04
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-04-23
- DEF 14A Proxy statement for shareholder vote 2026-04-02
- 10-K Annual financial report with audited statements 2026-03-27
Source: SEC EDGAR.
Annual results
5 years of annual figures for UTMD, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | $38.5M | $11.3M | $3.48 |
| 2024 | $40.9M | $13.9M | $3.96 |
| 2023 | $50.2M | $16.6M | $4.57 |
| 2022 | $52.3M | $16.5M | $4.52 |
| 2021 | $49.1M | $14.8M | $4.04 |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for UTMD. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open UTMD in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.